drugset / Trial / NCT01180374

The Effects of Cannabidiol and ∆-9-THC in Humans

NCT01180374

Phase 0 Completed 27 enrolled Yale University
RandomizedCrossoverQuadruple-blindBasic science

Summary

Cannabis is the most commonly used illicit substance in the US and herbal cannabis consists of a number of cannabinoids including Δ-9 THC and CBD. This study will characterize the interactive effects of the two major components of cannabis i.e. Δ-9-THC and CBD.

Timeline

Start
2010-02-01
Primary completion
2014-10-06
Completion
2014-10-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 5 mg
Subject Dronabinol Other / unclassified 0.035 mg/kg Intravenous

Indications

No indication recorded.